Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, today announced the appointment of Elizabeth Mily ...

Acquisition of biologics Contract Development and Manufacturing Organisation Avid Bioservices now completedGHO and Ampersand’s deep experience in ...

GHO Capital Partners and Ampersand Capital Partners announced the closing of the previously announced acquisition of Avid Bioservices (CDMO).

Special to The New York Times. TimesMachine is an exclusive benefit for home delivery and digital subscribers. Full text is unavailable for this digitized archive article. Subscribers may view the ...

US-based Nektar Therapeutics has signed a definitive agreement to divest its Huntsville, Alabama manufacturing facility and ...

Ampersand codes are preceded with an ampersand ... THIS DEFINITION IS FOR PERSONAL USE ONLY. All other reproduction requires permission.

Funds managed by GHO Capital Partners and Ampersand Capital Partners have signed a definitive agreement to acquire biologics contract development and manufacturing organisation (CDMO) Avid ...

timelines and quality are consistent across all product lines," says Ampersand President Damian McDonald. "We think that’s a very valuable proposition and something unique to the Canadian ...

SCIENCE: Trudeau Institute, Ampersand Biosciences producing tools for flu research with $1M grant SARANAC LAKE — Local research and biotechnology laboratories Trudeau Institute and Ampersand ...

Canada’s leading producer of gift, loyalty, insurance and identification cards, today announced their acquisition of Guelph, Ontario-based commercial printing house Ampersand Printing (Ampersand).